Previous 10 | Next 10 |
– Q4 2019 Total Preliminary Revenue of $78.4 to $79.4 million – – Updates 2020 Guidance – Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported prelimin...
Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 38 th Annual J.P. Morgan Healthcare Conference in San Francisco. Inoge...
Today, we will be studying why Inogen ( INGN ) is an attractive investment at the end of 2019. Company overview Inogen is a MedTech company that pioneered the development of POT (portable oxygen technology) for patients prescribed oxygen therapy for their respiratory disease. Previously,...
Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the Stifel 2019 Healthcare Conference in New York. Inogen’s Presiden...
Image source: The Motley Fool. Inogen Inc (NASDAQ: INGN) Q3 2019 Earnings Call Nov 5, 2019 , 4:30 p.m. ET Operator Continue reading
The following slide deck was published by Inogen, Inc. in conjunction with their 2019 Q3 earnings Read more ...
Inogen, Inc. (INGN) Q3 2019 Earnings Conference Call November 5, 2019 4:30 P.M. ET Company Participants Matt Bacso - Investor Relations Scott Wilkinson - President and Chief Executive Officer Ali Bauerlein - Chief Financial Officer and Co-Founder Conference Call Participants ...
Inogen (NASDAQ: INGN ) Q3 results : More news on: Inogen, Inc., Healthcare stocks news, Earnings news and commentary, Read more ...
Inogen (NASDAQ: INGN ): Q3 GAAP EPS of $0.31 beats by $0.08 . More news on: Inogen, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
– Q3 2019 Total Revenue of $91.8 million – – Confirms 2019 Guidance and Provides Initial 2020 Guidance – Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today re...
News, Short Squeeze, Breakout and More Instantly...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report second quarter 2024 financial results after the market closes on Tuesday, August 6, 2024. On the same day, the Company wil...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kevin P. Smith as General Counsel and Executive Vice President, Business Development, effective July 22, 2024. Mr. Smith jo...